Literature DB >> 18413589

N-acetylaspartate and N-acetylaspartylglutamate: neurobiology and clinical significance.

Eduardo E Benarroch1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18413589     DOI: 10.1212/01.wnl.0000311267.63292.6c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  47 in total

1.  Longitudinal whole-brain N-acetylaspartate concentration in healthy adults.

Authors:  D J Rigotti; I I Kirov; B Djavadi; N Perry; J S Babb; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-21       Impact factor: 3.825

2.  Whole-Brain N-Acetylaspartate Concentration Is Preserved during Mild Hypercapnia Challenge.

Authors:  S Chawla; Y Ge; H Lu; O Marshall; M S Davitz; G Fatterpekar; B J Soher; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-20       Impact factor: 3.825

3.  APOE genotype modulates proton magnetic resonance spectroscopy metabolites in the aging brain.

Authors:  Jesus J Gomar; Marc L Gordon; Dwight Dickinson; Peter B Kingsley; Aziz M Uluğ; Lynda Keehlisen; Sarah Huet; Justin J Buthorn; Jeremy Koppel; Erica Christen; Concepcion Conejero-Goldberg; Peter Davies; Terry E Goldberg
Journal:  Biol Psychiatry       Date:  2013-07-05       Impact factor: 13.382

4.  Altered brain mitochondrial metabolism in healthy aging as assessed by in vivo magnetic resonance spectroscopy.

Authors:  Fawzi Boumezbeur; Graeme F Mason; Robin A de Graaf; Kevin L Behar; Gary W Cline; Gerald I Shulman; Douglas L Rothman; Kitt F Petersen
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-30       Impact factor: 6.200

5.  Medial Frontal Lobe Neurochemistry in Autism Spectrum Disorder is Marked by Reduced N-Acetylaspartate and Unchanged Gamma-Aminobutyric Acid and Glutamate + Glutamine Levels.

Authors:  Andreia Carvalho Pereira; Inês R Violante; Susana Mouga; Guiomar Oliveira; Miguel Castelo-Branco
Journal:  J Autism Dev Disord       Date:  2018-05

6.  Global N-acetylaspartate in normal subjects, mild cognitive impairment and Alzheimer's disease patients.

Authors:  Lidia Glodzik; Marc Sollberger; Achim Gass; Amit Gokhale; Henry Rusinek; James S Babb; Jochen G Hirsch; Michael Amann; Andreas U Monsch; Oded Gonen
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

7.  Whole brain neuronal abnormalities in focal epilepsy quantified with proton MR spectroscopy.

Authors:  Ivan I Kirov; Ruben Kuzniecky; Hoby P Hetherington; Brian J Soher; Matthew S Davitz; James S Babb; Heath R Pardoe; Jullie W Pan; Oded Gonen
Journal:  Epilepsy Res       Date:  2017-12-02       Impact factor: 3.045

8.  Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration.

Authors:  Lutz Achtnichts; Oded Gonen; Daniel J Rigotti; James S Babb; Yvonne Naegelin; Iris-Katharina Penner; Kerstin Bendfeldt; Jochen Hirsch; Michael Amann; Ludwig Kappos; Achim Gass
Journal:  Eur J Radiol       Date:  2013-09-04       Impact factor: 3.528

9.  Brain MR spectroscopic abnormalities in "MRI-negative" tuberous sclerosis complex patients.

Authors:  William E Wu; Ivan I Kirov; Assaf Tal; James S Babb; Sarah Milla; Joseph Oved; Howard L Weiner; Orrin Devinsky; Oded Gonen
Journal:  Epilepsy Behav       Date:  2013-03-22       Impact factor: 2.937

10.  Investigation of NAA and NAAG dynamics underlying visual stimulation using MEGA-PRESS in a functional MRS experiment.

Authors:  Ricardo C G Landim; Richard A E Edden; Bernd Foerster; Li Min Li; Roberto J M Covolan; Gabriela Castellano
Journal:  Magn Reson Imaging       Date:  2015-12-02       Impact factor: 2.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.